Navigation Links
Erroneous Laboratory Operation May Lead To a Cancer Drug

An error in the laboratory may pave way to the discovery of a new drug for cancer. This was disclosed by Katherine Schaefer of Rochester University Medical Center. //This may be a foundation study for treatments associated with colon, skin, liver and oesophagal cancers.

Schaefer was studying to locate therapeutic measures for swelling in Crohn’s disease and ulcerative colitis which results in intense pain and diarrhoea. Cancer cells were used as controls for this study and a compound by the name PPAR-gamma modulator was being tested. Schaefer realized that a small error in her laboratory calculation resulted in the death of the cancer cells.

She also found that PPAR-gamma had killed all the epithelial lining of the tumor cells. In the mice this compound killed colon tumor with no side effects.

According to Schaefer, mode of action of PPAR-gamma is different from the current drugs. It attacks a section of cell cytoskeleton called tubulin. While tubulin is involved in building the cell arrangement, PPAR-gamma breaks it down. This indirectly indicates that the gamma compound could actually counter the effect of tumor cells to chemotherapy.

Schaefer also intends to pursue this study further and conduct more trials with mice on the same subject.
JYT
'"/>




Page: 1

Related medicine news :

1. Watch Out For the Erroneous Readings in the Glucose Meters
2. Medicare Sends out Reimbursement Checks Erroneously
3. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
4. Laboratory grown vegetarian meat
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. Laboratory Heart valve to study Heart diseases
7. NCFAD Nominated As Reference Laboratory for Bird Flu and BSE
8. British Laboratory Certifies Coke as Safe
9. India to Set Up Nicotine-Mapping Laboratory
10. A Laboratory Filtration System Kills 100 Percent Of Dangerous Microbes In Water
11. Death Of Woman Following Family Planning Operation Creates Panic
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing ... The three-day event was held at the Marriott Syracuse Downtown Hotel in Syracuse, New ... brand and network of independent hearing healthcare providers to help them stay ahead in ...
(Date:5/26/2017)... ... May 26, 2017 , ... The Radiology Business ... focus on current legislative activity and the latest regulatory concerns impacting RBMA members. ... Sept. 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, Tysons ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie ... are thrilled to partner with Cupron® to provide customers with a game changing ...
(Date:5/26/2017)... ... 2017 , ... Rob Lowe acts as host and helps educate and inform ... hiking in American. Viewers can reconnect with America as it explores some of the ... consumers have looked for an inventive new place for a family vacation, and have ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the ... of Eden” is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist ... to NYC when she was three. At six, they moved to Dayton, Ohio, where ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... WASHINGTON , May 10, 2017  The ... doctors or employees of sleep therapy clinics to ... a sleep therapy clinic is involved in a ... as interested in hearing from an employee of ... involved in a kickback scheme to provide medical practice ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
Breaking Medicine Technology: